Trinity Biotech Plc (TRIB) Withdraws Troponin FDA 510(k) Submission After Meeting
Tweet Send to a Friend
Trinity Biotech plc (Nasdaq: TRIB) announced today that it is withdrawing its 510(k) premarket notification submission for the Meritas Troponin-I ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
